Skip to the main content.
Talk to sales Start for free
Talk to sales Start for free

2 min read

Finalized HIPAA changes to strengthen reproductive healthcare privacy

Finalized HIPAA changes to strengthen reproductive healthcare privacy

The Office for Civil Rights (OCR) of the Department of Health and Human Services (HHS) has recently issued a groundbreaking Final Rule. This regulatory update bolsters privacy protections for individuals seeking or obtaining lawful reproductive healthcare services.


What happened

The Final Rule, introduced in response to President Biden's Executive Order 14076, introduces changes to the Health Insurance Portability and Accountability Act (HIPAA) framework. These modifications are designed to shield reproductive health data from being accessed, used, or disclosed for criminal, civil, or administrative investigations or liability imposition on individuals seeking or providing such care.


Going deeper

The Final Rule explicitly prohibits covered entities and business associates from engaging in the following activities:

  • Conducting investigations or imposing liability on individuals solely for the act of seeking, obtaining, providing, or facilitating lawful reproductive healthcare.
  • Identifying individuals for the purpose of such investigations or liability imposition.

This safeguard ensures that pursuing reproductive services cannot be used as grounds for legal action against the patient or healthcare provider.


In the know

To further strengthen privacy protections, the Final Rule mandates that covered entities and business associates obtain a signed attestation from any individual or entity requesting protected health information (PHI) potentially related to reproductive healthcare. This attestation must confirm that the request and associated disclosure are not for the prohibited purposes outlined above.

The attestation requirement applies to PHI requests for the following purposes:

  • Health oversight activities
  • Judicial and administrative proceedings
  • Law enforcement purposes
  • Disclosures to coroners and medical examiners

By implementing this attestation process, the OCR tries to create an additional layer of accountability and transparency in the handling of sensitive reproductive health data.


Why it matters

The OCR's Final Rule on reproductive health privacy represents a milestone in the ongoing efforts to safeguard sensitive personal information. By prohibiting the misuse of reproductive health data and mandating compliance measures, the rule empowers individuals to exercise their right to privacy and access healthcare without fear of repercussion.


The bottom line 

Complying with the Final Rule's provisions may present some challenges for covered entities and business associates. Healthcare organizations and medical record custodians must diligently assess whether incoming requests for PHI fall under the prohibited categories and could be related to reproductive healthcare. Establishing processes to obtain the required attestations before releasing records will be needed.

Furthermore, covered entities must update their notice of privacy practices to include the new protections on the use and disclosure of reproductive health information. Ensuring that these updated notices are prominently displayed on the organization's website is a compliance requirement.



Does HIPAA apply?

Yes, the Final Rule issued by the Office for Civil Rights at the U.S. Department of Health & Human Services modifies the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule to support reproductive health care privacy. It prohibits the use or disclosure of protected health information (PHI) related to lawful reproductive health care under certain circumstances, thereby reinforcing the application of HIPAA in safeguarding patient confidentiality and privacy regarding reproductive health care.


Do I need consent?

The Final Rule requires covered health care providers, health plans, and health care clearinghouses to obtain a signed attestation when receiving requests for PHI potentially related to reproductive health care. This attestation serves as written confirmation that the use or disclosure of PHI is not for a prohibited purpose, thus emphasizing the importance of proper authorization and compliance with privacy regulations when handling reproductive health-related information.


What can I use?

To comply with the Final Rule and support reproductive health care privacy, covered entities can revise their notice of privacy practices (NPPs) as required by the final rule. Additionally, they can use secure email platforms and services designed for handling protected health information to communicate, ensuring adherence to the strengthened privacy protections outlined in the final rule.

Learn more: HIPAA Compliant Email: The Definitive Guide







Subscribe to Paubox Weekly

Every Friday we'll bring you the most important news from Paubox. Our aim is to make you smarter, faster.